VISIT US IN CHICAGO JUNE 2-4 AT BOOTH 2073!

Dr. Annunziata on Efforts to Prevent Gynecologic Cancers

Christina M. Annunziata, MD, PhD
Published: Tuesday, Aug 15, 2017



Christina M. Annunziata, MD, PhD, investigator, Women's Malignancies Branch, head, Translational Genomics Section, National Cancer Institute, discusses focusing efforts to prevent gynecologic cancers.

Researchers need to think about treating patients earlier and determining how to prevent cancer from forming in the first place, she explains. There needs to be more examinations in high-risk groups and identify patients who are at risk for these gynecologic cancers—then work to help prevent a cancer diagnosis from occurring.

Progress is being made for therapies in the upfront and recurrent settings, but there needs to be more of a push in the prevention setting, she concludes.


Christina M. Annunziata, MD, PhD, investigator, Women's Malignancies Branch, head, Translational Genomics Section, National Cancer Institute, discusses focusing efforts to prevent gynecologic cancers.

Researchers need to think about treating patients earlier and determining how to prevent cancer from forming in the first place, she explains. There needs to be more examinations in high-risk groups and identify patients who are at risk for these gynecologic cancers—then work to help prevent a cancer diagnosis from occurring.

Progress is being made for therapies in the upfront and recurrent settings, but there needs to be more of a push in the prevention setting, she concludes.

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Community Practice Connections™: Redefining Ovarian Cancer Treatment Paradigms by Maximizing Therapeutic Outcomes with PARP InhibitorsSep 29, 20182.0
Community Practice Connections™: 1st Annual School of Nursing Oncology™Oct 31, 20181.5
Publication Bottom Border
Border Publication
x